Mitsikostas, Dimos D. http://orcid.org/0000-0002-4691-3388
Waeber, Christian http://orcid.org/0000-0001-6078-0027
Sanchez-del-Rio, Margarita http://orcid.org/0000-0001-7724-2890
Raffaelli, Bianca
Ashina, Håkan http://orcid.org/0000-0002-6268-727X
Maassen van den Brink, Antoinette http://orcid.org/0000-0001-7176-126X
Andreou, Anna
Pozo-Rosich, Patricia
Rapoport, Alan http://orcid.org/0000-0002-6311-8562
Ashina, Messoud
Moskowitz, Michael A.
Article History
Accepted: 12 June 2023
First Online: 12 July 2023
Competing interests
: D.D.M. has received honoraria, research and travel grants from Allergan/Abbvie, Amgen, Biogen, Cefaly, Genesis Pharma, Electrocore, Eli Lilly, Lundbeck, Merk-Serono, Mertz, Novartis, Roche, Sanofi, Specifar and Teva; has participated in clinical trials for Amgen, Cefaly, Electrocore, Eli Lilly, Genesis Pharma, Lundbeck, Mertz, Novartis, Specifar and Teva as principal investigator; is President of the board of the Hellenic Headache Society; and is Co-chairman of the management group of the Headache Panel at the European Academy of Neurology. M.S.d.R. has received honoraria and travel grants from Allergan/Abbvie, Eli Lilly, Novartis and Teva; and is Secretary of the Board of the European Headache Federation. B.R. has received honoraria from Allergan/Abbvie, Eli Lilly, Hormosan, Novartis and Teva; and has received research grants from the Charité Clinician Scientist Program, the German Migraine and Headache Society (Deutsche Migräne- und Kopfschmerzgesellschaft) and Novartis. H.A. reports personal fees from Teva, outside the submitted work. A.M.v.d.B. has received honoraria, research and/or travel grants from Allergan/Abbvie, Amgen/Novartis, Eli Lilly, Satsuma and Teva as principal investigator; is First Vice President of the European Headache Federation; and is a board member of the Dutch Headache Society. A.A. has received speaker and/or consultation fees from AbbVie, Eli Lilly and Neuresta Inc. P.P.-R. has received honoraria as a consultant and speaker for AbbVie, Biohaven, Chiesi, Eli Lilly, Lundbeck, Medscape, Novartis Pfizer and Teva; has received research grants from AbbVie, Novartis and Teva; has received funding for clinical trials from Alder, Amgen, Biohaven, Electrocore, Eli Lilly, Lundbeck, Novartis and Teva; and is the founder of ExternalRef removed. A.R. has received honoraria as a consultant and speaker for AbbVie, Amgen, Biohaven, Cala Health, Impel, Lundbeck, Pfizer, Teva, Theranica and Xoc. M.A. has received personal fees from AbbVie, Amgen, Eli Lilly, Lundbeck, Novartis, Pfizer and Teva; has participated in clinical trials as the principal investigator for AbbVie, Amgen, Eli Lilly, Lundbeck, Novartis and Teva; has received research grants from Lundbeck Foundation, Novo Nordisk Foundation and Novartis; and serves as Associate Editor for <i>Cephalalgia</i>, <i>Journal of Headache and Pain</i> and <i>Brain</i>. C.W. and M.A.M. declare no competing interests.